SIASUN(SZ:300024) Sou Hu Cai Jing·2025-08-11 01:57Core Viewpoint - The article highlights the strong performance of the Sci-Tech Innovation 100 Index and its ETF, driven by advancements in robotics and related technologies, particularly in the context of the 2025 World Robot Conference held in Beijing [3][4]. Group 1: Market Performance - As of August 11, 2025, the Sci-Tech Innovation 100 Index rose by 1.07%, with notable gains from constituent stocks such as Shengyi Electronics (up 8.73%) and Huazhu High-Tech (up 8.27%) [3]. - The Sci-Tech 100 Index ETF increased by 1.08%, with a latest price of 1.13 yuan, and has seen a 2.01% rise over the past week, ranking 2nd among comparable funds [3]. - The ETF's trading volume was 16.11 million yuan, with a turnover rate of 0.25% [3]. Group 2: Industry Insights - The integration of cutting-edge technologies like AI, biomimicry, and new materials is driving the robotics industry towards intelligent upgrades and large-scale applications [4]. - The revenue for the robotics industry is projected to reach nearly 240 billion yuan in 2024, with industrial robot production expected to grow by 35.6% year-on-year in the first half of 2025 [4]. Group 3: ETF Performance Metrics - The Sci-Tech 100 Index ETF has seen a net value increase of 15.76% over the past six months, ranking in the top 17.25% among equity funds [5]. - The ETF's highest monthly return since inception was 27.67%, with an average monthly return of 8.48% during rising months [5]. - The ETF's management fee is 0.15%, and its tracking error over the past month is 0.013%, indicating high tracking precision compared to similar funds [5][6]. Group 4: Fund Growth - The Sci-Tech 100 Index ETF experienced a significant growth in scale, increasing by 52.16 million yuan over the past week, ranking 2nd among comparable funds [4]. - The ETF's share count rose by 27 million shares in the same period, ranking 3rd among comparable funds [4]. Group 5: Top Holdings - As of July 31, 2025, the top ten weighted stocks in the Sci-Tech Innovation 100 Index accounted for 23.52% of the index, including companies like Borui Pharmaceutical and BeiGene [6].